BBVA USA Bancshares’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $4.39M | Buy |
40,577
+8,672
| +27% | +$928K | 0.21% | 113 |
|
|
2020
Q4 | $3.42M | Sell |
31,905
-245
| -0.8% | -$23.5K | 0.18% | 132 |
|
|
2020
Q3 | $2.88M | Sell |
32,150
-573
| -2% | -$53.9K | 0.17% | 130 |
|
|
2020
Q2 | $3.21M | Buy |
32,723
+1,429
| +5% | +$126K | 0.19% | 118 |
|
|
2020
Q1 | $2.38M | Buy |
31,294
+2,817
| +10% | +$240K | 0.17% | 123 |
|
|
2019
Q4 | $2.52M | Sell |
28,477
-22
| -0.1% | -$1.83K | 0.14% | 146 |
|
|
2019
Q3 | $2.16M | Sell |
28,499
-791
| -3% | -$54.2K | 0.14% | 157 |
|
|
2019
Q2 | $2.13M | Sell |
29,290
-2,793
| -9% | -$220K | 0.13% | 156 |
|
|
2019
Q1 | $2.58M | Sell |
32,083
-432
| -1% | -$35.3K | 0.16% | 139 |
|
|
2018
Q4 | $3M | Sell |
32,515
-829
| -2% | -$72.9K | 0.21% | 110 |
|
|
2018
Q3 | $3.15M | Sell |
33,344
-97
| -0.3% | -$9.2K | 0.19% | 124 |
|
|
2018
Q2 | $3.1M | Sell |
33,441
-2,279
| -6% | -$223K | 0.2% | 121 |
|
|
2018
Q1 | $3.38M | Sell |
35,720
-1,476
| -4% | -$162K | 0.22% | 103 |
|
|
2017
Q4 | $3.6M | Sell |
37,196
-1,453
| -4% | -$137K | 0.23% | 103 |
|
|
2017
Q3 | $3.43M | Sell |
38,649
-326
| -0.8% | -$24.8K | 0.22% | 108 |
|
|
2017
Q2 | $2.83M | Buy |
38,975
+669
| +2% | +$45K | 0.19% | 125 |
|
|
2017
Q1 | $2.5M | Sell |
38,306
-1,216
| -3% | -$76.5K | 0.17% | 135 |
|
|
2016
Q4 | $2.48M | Buy |
39,522
+4,349
| +12% | +$265K | 0.17% | 131 |
|
|
2016
Q3 | $2.22M | Buy |
35,173
+1,113
| +3% | +$72.1K | 0.16% | 136 |
|
|
2016
Q2 | $2.11M | Sell |
34,060
-1,237
| -4% | -$75.4K | 0.16% | 139 |
|
|
2016
Q1 | $2.02M | Buy |
35,297
+5,862
| +20% | +$327K | 0.15% | 150 |
|
|
2015
Q4 | $1.74M | Buy |
29,435
+4,021
| +16% | +$232K | 0.13% | 160 |
|
|
2015
Q3 | $1.38M | Sell |
25,414
-7,083
| -22% | -$461K | 0.11% | 167 |
|
|
2015
Q2 | $2.18M | Sell |
32,497
-146
| -0.4% | -$9.53K | 0.12% | 156 |
|
|
2015
Q1 | $1.91M | Sell |
32,643
-1,854
| -5% | -$112K | 0.09% | 194 |
|
|
2014
Q4 | $2.26M | Sell |
34,497
-2,101
| -6% | -$132K | 0.1% | 184 |
|
|
2014
Q3 | $2.11M | Buy |
36,598
+596
| +2% | +$33.1K | 0.09% | 191 |
|
|
2014
Q2 | $2.03M | Sell |
36,002
-2,686
| -7% | -$141K | 0.09% | 202 |
|
|
2014
Q1 | $1.99M | Sell |
38,688
-3,341
| -8% | -$169K | 0.09% | 198 |
|
|
2013
Q4 | $2.22M | Sell |
42,029
-6,377
| -13% | -$313K | 0.1% | 191 |
|
|
2013
Q3 | $2.17M | Sell |
48,406
-21,900
| -31% | -$971K | 0.1% | 189 |
|
|
2013
Q2 | $2.91M | Buy |
+70,306
| New | +$3.07M | 0.15% | 165 |
|
Other funds holding ABBV
BBVA USA Bancshares's ABBV Position: Q1 2021 in Review
BBVA USA Bancshares increased its AbbVie (ABBV) stake by 27% in Q1 2021, buying an estimated $928K and bringing the position to 40,577 shares worth $4.39M. The position accounts for 0.21% of the portfolio, ranked #113.
BBVA USA Bancshares first reported a position in ABBV in Q2 2013 and has held it in 32 quarters since. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.
- BBVA USA Bancshares held 40,577 shares of AbbVie worth $4.39M as of Q1 2021.
- BBVA USA Bancshares bought 8,672 AbbVie shares in Q1 2021, an estimated $928K.
- AbbVie made up 0.21% of BBVA USA Bancshares's portfolio in Q1 2021, its #113 holding.
- BBVA USA Bancshares first reported a position in AbbVie in Q2 2013 and has held it in 32 quarters since.
- 2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.